|
End-of-day quote
Dhaka S.E.
2026-08-25
|
5-day change | 1st Jan Change | ||
| 79.70 BDT | 0.00% |
|
-2.92% | +12.41% |
| Market Cap | 17.44B 142M 122M 114M 104M 196M 13.52B 198M 1.34B 523M 6.82B 533M 521M 22.6B | P/E 2024 |
5.9x | P/E 2025 | 6.29x |
|---|---|---|---|---|---|
| Enterprise Value | 40.31B 328M 281M 263M 241M 454M 31.27B 458M 3.11B 1.21B 15.77B 1.23B 1.2B 52.24B | EV / Sales 2024 |
1.15x | EV / Sales 2025 | 1.06x |
| Free-Float |
51.84% | Yield 2024 |
5.11% | Yield 2025 | 4.85% |
| 1 week | -2.92% | ||
| Current month | -4.67% | ||
| 1 month | -3.74% | ||
| 3 months | +4.18% | ||
| 6 months | -0.62% | ||
| Current year | +12.41% |
| 1 week | 79.2 | 81.6 | |
| 1 month | 79.2 | 84.9 | |
| Current year | 70.6 | 88.7 | |
| 1 year | 68.6 | 88.7 | |
| 3 years | 62.6 | 94.5 | |
| 5 years | 62.6 | 117.7 | |
| 10 years | 54.2 | 122.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 82 | 1995-09-29 | |
| Director of Finance/CFO | - | - | |
Asad Shamsuddin
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 82 | 1975-03-16 | |
| Director/Board Member | 76 | 1981-04-14 | |
| Chairman | 69 | 2018-09-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | -2.92% | -2.92% | -6.24% | 137M | ||
| -1.08% | +0.63% | +77.40% | +122.79% | 1,111B | ||
| +0.53% | +0.76% | +53.11% | +64.31% | 658B | ||
| +0.47% | +2.64% | +28.05% | +81.17% | 467B | ||
| +0.92% | +4.97% | +42.94% | +43.69% | 369B | ||
| +1.25% | +4.00% | +25.87% | +42.82% | 301B | ||
| +3.02% | +7.92% | +4.24% | +16.06% | 256B | ||
| -0.36% | +3.98% | +53.29% | +72.48% | 240B | ||
| +2.86% | +5.27% | -15.42% | -52.34% | 207B | ||
| +1.38% | +3.72% | +30.33% | +93.56% | 182B | ||
| Average | +0.93% | +3.90% | +29.69% | +47.83% | 379.11B | |
| Weighted average by Cap. | +0.56% | +4.68% | +45.87% | +72.12% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 31.93B 260M 223M 209M 191M 360M 24.77B 363M 2.46B 958M 12.5B 975M 954M 41.38B | 35.94B 292M 251M 235M 214M 405M 27.87B 409M 2.77B 1.08B 14.06B 1.1B 1.07B 46.57B |
| Net income | 2.46B 19.98M 17.12M 16.05M 14.66M 27.66M 1.91B 27.93M 189M 73.68M 961M 75.03M 73.4M 3.18B | 2.43B 19.76M 16.93M 15.87M 14.49M 27.35M 1.88B 27.62M 187M 72.85M 950M 74.19M 72.58M 3.15B |
| Net Debt | 22.18B 180M 155M 145M 132M 250M 17.2B 252M 1.71B 665M 8.68B 678M 663M 28.74B | 22.87B 186M 159M 149M 136M 258M 17.74B 260M 1.76B 686M 8.95B 699M 684M 29.64B |
Employees
9,025
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-24 | BDT 79.70 | 0.00% | 104,665 |
| 26-08-24 | BDT 79.70 | -0.87% | 182,530 |
| 26-08-23 | BDT 80.40 | -0.86% | 126,889 |
| 26-08-20 | BDT 81.10 | +0.25% | 89,774 |
| 26-08-19 | BDT 80.90 | +0.50% | 137,088 |
- Stock Market
- Stocks
- ACMELAB Stock
Select your edition
All financial news and data tailored to specific country editions
















